Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Irreversible Electroporation for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study

NCT07263451 is registered in ClinicalTrials.gov with Tian'an Jiang as lead sponsor.

NCT NCT07263451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07263451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Irreversible Electroporation for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study
Lead sponsor
Tian'an Jiang
Phase
Not applicable
Overall status
Recruiting
Start date
December 11, 2025
Completion date
May 15, 2026
Enrollment
24 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer